Hydroxychloroquine / azithromycin in COVID-19: The association between time to treatment and case fatality rate

BACKGROUND: Currently, there is no formally accepted pharmacological treatment for COVID-19. MATERIALS AND METHODS: We included COVID-19 outpatients of a Peruvian primary care center from Lima, Peru, who were treated between April 30 - September 30, 2020, with hydroxychloroquine and azithromycin. Lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Accinelli, Roberto Alfonso, Ynga-Meléndez, Grisel Jesús, León-Abarca, Juan Alonso, López, Lidia Marianella, Madrid-Cisneros, Juan Carlos, Mendoza-Saldaña, Juan Diego
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438859/
https://www.ncbi.nlm.nih.gov/pubmed/34534686
http://dx.doi.org/10.1016/j.tmaid.2021.102163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438859/
https://www.ncbi.nlm.nih.gov/pubmed/34534686
http://dx.doi.org/10.1016/j.tmaid.2021.102163

Ejemplares similares